Benexate hydrochloride is a cytoprotective agent useful in the treatment of ulcers. In
experimental models benexate inhibits the decrease of PGE2 and PGI2 induced by
indomethacin or stress. Its relatively long duration of action offers a distinct advantage
over other cytoprotective drugs.